AIMD — Ainos, Inc.

Nasdaq · Information Technology · Technology Hardware, Storage & Peripherals · CIK 1014763 ·
Last close
$3.16
Market Cap
$23.27M
52W High
$3.88
52W Low
$1.31
ADV30
533,673
Next earnings
Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 161 -602 -2,283,647 -2,459,800 22,081,583 2,841,422 16,389,637
Dec 2025 11,120 9,521 -4,297,657 -4,468,298 20,871,108 417,353 13,308,526
Sep 2025 2,167 1,690 -2,784,193 -2,931,702 22,679,340 1,128,217 12,634,391
Jun 2025 4,663 3,726 -3,745,687 -4,084,990 23,922,176 1,223,184 12,479,390

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-4,614,697
Investing CF
$-2,223
Financing CF
$1,008,461
CapEx
$-54,835
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-4.32
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-67,520,328
Inventory
$295,565
Receivables
$22
ST Investments
EBIT TTM
$-14,058,309
Pretax Income TTM
$-14,770,212
Interest Exp TTM
$711,903
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$18,111
EBITDA
$-8,334,230
Free Cash Flow
$1,533,462
Enterprise Value
$24,014,068
Total Cash
$2,841,422
Total Debt
$13,812,940
Shares Out
7,364,542
Trailing EPS
$-2.88
Book Value
$0.93
ROE
-148.2%
ROA
-33.8%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 124,157 -13,990,408 -14,771,012 20,871,108 13,308,526 -4,614,697
Dec 2024 20,729 -13,841,204 -14,863,161 28,820,199 13,303,889 -5,808,267
Dec 2023 122,112 -13,206,396 -13,770,549 31,841,804 7,394,223 -4,694,668
Dec 2022 3,519,627 -13,976,212 -14,006,690 37,109,014 2,481,008 -3,040,737

TTM Snapshot

Revenues TTM
$212,274
NetIncome TTM
$-1,165,561
OpCashFlow TTM
$0
Assets (Latest)
$596,626
Forward EPS

Peers — same industry

TickerNameMarket CapLastDaily %
WETH Wetouch Technology Inc. $18.49M $1.55
YIBO Planet Image International Ltd $32.50M $0.99
MYND Mynd.ai, Inc. $13.36M $0.29
TACT TRANSACT TECHNOLOGIES INC $43.88M $4.27
ZEPP Zepp Health Corp $74.45M $8.80

News headlines (Yahoo Finance, 1h cache)

VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence
2026-05-20 12:00 · Yahoo
Zacks Small-Cap Research Highlights Ainos' Smell AI Commercialization
2026-05-18 14:15 · Yahoo
AIMD Using AI Technology to Advance Semi Manufacturing
2026-05-14 10:07 · Yahoo
12 Information Technology Stocks Moving In Wednesday's After-Market Session
2026-05-13 21:06 · Yahoo
Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets
2026-05-13 20:30 · Yahoo
Why Ainos (AIMD) May Be Positioning Itself For A Bigger AI Commercialization Push
2026-05-12 21:00 · Yahoo
Ainos Updates Standard Industrial Classification Code to Reflect Smell AI Business Focus
2026-05-11 12:00 · Yahoo
VASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical Scalability
2026-04-17 12:00 · Yahoo
Ainos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital Environments
2026-04-08 12:00 · Yahoo
VASRO Research Highlights Ainos' Smell AI Commercial Progress and 2026 Deployment Momentum
2026-04-01 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.